Drug Profile
Gallium-68-SH 7139
Alternative Names: Ga68-SH-7139; Gallium-68-SH7139Latest Information Update: 28 Aug 2018
Price :
$50
*
At a glance
- Originator SHAL Technologies
- Developer SHAL Technologies; Zentralklinik Bad Berka
- Class Antineoplastics; Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Non-Hodgkin's lymphoma
Most Recent Events
- 28 Aug 2018 No recent reports of development identified for phase-0 development in Non-Hodgkin's-lymphoma(Diagnosis) in Germany (IV, Injection)
- 28 Jul 2015 Phase-0 for Non-Hodgkin's lymphoma (Diagnosis) in Germany (IV) before July 2015